| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $102.4M | $57.8M | $56.3M |
| YoY Revenue Growth % | +77.3% | +2.6% | — |
| Gross Profit | $34.3M | $24.9M | — |
| Gross Margin % | 33.5% | 43.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$140.3M | -$89.6M | -$129.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$293.3M | -$98.8M | -$56.0M |
| EBITDA (Normalized) | -$139.5M | -$87.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | -$18.9M | -$68.7M |
| Capital Expenditures (CapEx) | $1.1M | $2.2M | — |
| Free Cash Flow (FCF) | — | -$21.1M | -$68.7M |
| FCF Margin % | — | -36.5% | -80.0% |
| Return on Invested Capital (ROIC %) | -31.9% | -13.0% | — |
| Cash & Short-Term Equivalents | $204.7M | $317.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $552.0M | $860.0M | — |